These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20651408)

  • 1. Lack of prognostic value of topoisomerase II alpha in patients with breast cancer: analysis with tissue microarray.
    Sheen-Chen SM; Huang CY; Zhang H; Huang CC; Tang RP
    Anticancer Res; 2010 Jun; 30(6):2459-62. PubMed ID: 20651408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-binding protein-3 in breast cancer: analysis with tissue microarray.
    Sheen-Chen SM; Zhang H; Huang CC; Tang RP
    Anticancer Res; 2009 Apr; 29(4):1131-5. PubMed ID: 19414355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer.
    Rody A; Karn T; Ruckhäberle E; Müller V; Gehrmann M; Solbach C; Ahr A; Gätje R; Holtrich U; Kaufmann M
    Breast Cancer Res Treat; 2009 Feb; 113(3):457-66. PubMed ID: 18340528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of prognostic value of death-associated protein kinase 1 in breast cancer.
    Chou SE; Huang CY; Sheen-Chen SM; Liu YW; Tsai CH; Lin YH; Huang CC; Tang RP
    Anticancer Res; 2011 Oct; 31(10):3633-6. PubMed ID: 21965790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transducer and activator of transcription 1 in breast cancer: analysis with tissue microarray.
    Sheen-Chen SM; Huang CC; Tang RP; Yang CH; Chou FF; Eng HL
    Anticancer Res; 2007; 27(4B):2481-6. PubMed ID: 17695542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of prognostic value of insulin-like growth factor-1 in patients with breast cancer: analysis with tissue microarray.
    Sheen-Chen SM; Chou FF; Hsu W; Huang CC; Eng HL; Tang RP
    Anticancer Res; 2007; 27(5B):3541-4. PubMed ID: 17972515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of focal adhesion kinase in breast cancer by tissue microarrays.
    Sheen-Chen SM; Huang CY; Chan YC; Tsai CH; Chi SY; Wu SC; Huang CC; Tang RP; Eng HL; Ko SF; Lee YW; Liang JL; Huang EY; Chen HC; Rau KM
    Anticancer Res; 2013 Mar; 33(3):1169-73. PubMed ID: 23482798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase II alpha expression correlates with diminished disease-free survival in invasive breast cancer.
    O'Connor JK; Hazard LJ; Avent JM; Lee RJ; Fischbach J; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1411-5. PubMed ID: 16750309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.
    Kim EJ; Lee YS; Kim YJ; Kim MJ; Ha YS; Jeong P; Lee OJ; Kim WJ
    Urology; 2010 Jun; 75(6):1516.e9-13. PubMed ID: 19913893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.
    Manaios L; Tsiambas E; Alevizaki M; Karameris A; Alexopoulou D; Lambropoulou S; Moreas H; Kravvaritis C; Fotiades PP; Goula K; Patsouris E; Athanassiou AE; Koutras D; Katsilambros N
    J BUON; 2008; 13(4):537-41. PubMed ID: 19145676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 and topoisomerase IIalpha: possible predictors of response to neoadjuvant chemotherapy for breast cancer patients.
    Zhu L; Li YF; Chen WG; He JR; Peng CH; Zhu ZG; Li HW
    Chin Med J (Engl); 2008 Oct; 121(20):1965-8. PubMed ID: 19080257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of Topoisomerase II in female breast cancer.
    Koren R; Rath-Wolfson L; Ram E; Itzhac OB; Schachter B; Klein B; Gal R; Dreznik Z
    Oncol Rep; 2004 Oct; 12(4):915-9. PubMed ID: 15375522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
    ; Tanner M; Isola J; Wiklund T; Erikstein B; Kellokumpu-Lehtinen P; Malmström P; Wilking N; Nilsson J; Bergh J
    J Clin Oncol; 2006 Jun; 24(16):2428-36. PubMed ID: 16682728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
    Bouchalová K; Trojanec R; Kolár Z; Cwiertka K; Cernáková I; Mihál V; Hajdúch M
    Neoplasma; 2006; 53(5):393-401. PubMed ID: 17013533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer.
    Villman K; Sjöström J; Heikkilä R; Hultborn R; Malmström P; Bengtsson NO; Söderberg M; Saksela E; Blomqvist C
    Acta Oncol; 2006; 45(5):590-6. PubMed ID: 16864174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of signal transducers and activators of transcription 3 in breast cancer.
    Sheen-Chen SM; Huang CC; Tang RP; Chou FF; Eng HL
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2286-90. PubMed ID: 18768494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification and overexpression of topoisomerase IIalpha predict response to anthracycline-based therapy in locally advanced breast cancer.
    Coon JS; Marcus E; Gupta-Burt S; Seelig S; Jacobson K; Chen S; Renta V; Fronda G; Preisler HD
    Clin Cancer Res; 2002 Apr; 8(4):1061-7. PubMed ID: 11948114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.